Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine
- 18 April 2000
- Vol. 18 (23), 2476-2481
- https://doi.org/10.1016/s0264-410x(00)00047-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteinsVaccine, 1999
- Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for MemoryThe Journal of Infectious Diseases, 1999
- Conjugate Meningococcal Serogroup A and C Vaccine: Reactogenicity and Immunogenicity in United Kingdom InfantsThe Journal of Infectious Diseases, 1996
- Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccineVaccine, 1996
- Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine designMicrobiology, 1996
- Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, ChileVaccine, 1995
- Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, BrazilThe Lancet, 1992
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972